(Nanatinostat + valganciclovir) by Viracta Therapeutics for Solid Tumor: Likelihood of Approval
(Nanatinostat + valganciclovir) is under clinical development by Viracta Therapeutics and currently in Phase II for Solid Tumor.
(Nanatinostat + valganciclovir) is under clinical development by Viracta Therapeutics and currently in Phase II for Solid Tumor.
What's Your Reaction?
